An Acupuncture Study for Cancer Survivors With Joint Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

English- or Spanish-speaking adults

Non white or Hispanic women with a prior cancer diagnosis

Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment

Worst pain rated ≥4 on a 0-10 scale in the preceding week

Disqualifiers

Completed active treatment (chemotherapy, surgery, radiation, transplantation) <4 weeks prior to study

Maintenance therapies are allowed

Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)

Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acupuncture

    Procedure/Surgery

    Acupuncture is a non-pharmacological intervention that does not involve the use of any therapeutic agents or devices. Participants will receive 10 weekly treatments over 10 weeks.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: AcupunctureExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Study feasibility as measured by rates of enrollment

The primary purpose of this study is to determine the feasibility of studying an acupuncture intervention for chronic musculoskeletal pain in racially/ethnically diverse, community-based cancer survivors.

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.